American Medicines Company, PBC
A public-benefit company aiming to re-establish large-scale domestic production of generic oral solid dose (OSD) medicines for the U.S. market. The organization emphasizes continuous manufacturing, at-line/in-line analytical testing, automation, transparent domestic supply chains, surge capacity for strategic stockpiles, and adherence to high quality and regulatory standards.
Industries
Nr. of Employees
small (1-50)
American Medicines Company, PBC
Products
Portfolio of oral solid dose generic medicines (targeted)
Planned production portfolio targeting a set of commonly prescribed generic OSD molecules (including 18 of the top 40 drug molecules on a referenced formulary), produced for the U.S. market.
Portfolio of oral solid dose generic medicines (targeted)
Planned production portfolio targeting a set of commonly prescribed generic OSD molecules (including 18 of the top 40 drug molecules on a referenced formulary), produced for the U.S. market.
Services
Establish and operate manufacturing infrastructure to produce oral solid dose generic medicines exclusively for domestic supply.
Design and implement continuous manufacturing lines with integrated analytical testing and automation to enable high-volume, consistent production.
Maintain additional production capacity and operational readiness to supply national stockpiles and meet surge demand.
Streamline packaging workflows and deploy 3-D printing where applicable to improve packaging flexibility and responsiveness.
Access to regulatory strategy, compliance expertise and training through partnership with a regulatory and compliance consulting firm.
Establish and operate manufacturing infrastructure to produce oral solid dose generic medicines exclusively for domestic supply.
Design and implement continuous manufacturing lines with integrated analytical testing and automation to enable high-volume, consistent production.
Maintain additional production capacity and operational readiness to supply national stockpiles and meet surge demand.
Streamline packaging workflows and deploy 3-D printing where applicable to improve packaging flexibility and responsiveness.
Access to regulatory strategy, compliance expertise and training through partnership with a regulatory and compliance consulting firm.
Expertise Areas
- Oral solid dose (OSD) manufacturing
- Continuous manufacturing
- Quality assurance and regulatory compliance
- Supply chain resilience and sourcing strategy
Key Technologies
- Continuous manufacturing
- At-line and in-line analytical testing
- Automation and shop-floor control systems
- 3D printing for packaging and operations